At a glance
ClinicalIndex Comparison RecordN/AActive· 600 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gene Modifiers of Cystic Fibrosis Lung Disease
In Brief
An observational study for Cystic Fibrosis and Lung Diseases. Active but no longer recruiting, targeting 600 participants across 1 site.
Detailed Summary
The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis, Lung Diseases
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/AActive
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
Enrollment StartSep 2001
First PostedMay 2002
TodayJul 2026
Primary CompletionJul 2027
First PostedMay 21, 2002
Enrollment StartSep 1, 2001
Primary CompletionJul 1, 2027
TodayJul 2, 2026
Enrollment to primary: 25.8 yearsPosted 24.1 years agoPrimary completion in 12 months